However, in some tumor models such as murine adenocarcinoma TSA breast cancer, the fractionated protocol was more effective than the single-dose protocol at inducing the abscopal effect when combined with anti–CTLA-4 therapy [38]. The gene discussed is CTLA4; the disease is breast cancer.